​

​

Principle Investigator – Phase IV
Leuprogen in the management of endometrioss, leiomyomata uteri and prostate cancer

 

Principle Investigator – Phase IV
Study to evaluate the safety and immnogenicity of Neukine in clinical practices

​

​

Principle Investigator – Phase IV

Study to evaluate safety & efficacy of IP in HER2 positive Breast Cancer as part of a treatment regimen consisting of Doxorubicin, Cyclophosphamide with Taxane.

​

​

Principle Investigator – Phase IV

Study of IP in combination with Trastuzumab and Docetaxel in first line treatment of Indian patients with HER2 positive Advanced Breast Cancer.

​

​

Principle Investigator – Phase III
Antiemetics in Chemotherapy induced nausea and vomiting

 

 

Principle Investigator – Phase III
Epoetin Alfa plus standard supportive care versus standard supportive care in anaemic patients with metastasis breast cancer receiving standard chemotherapy

​

​

Principle Investigator – Phase II

Study of LEP-ETU for efficacy and safety in patients with metastasis breast cancer

​

​

Principle Investigator – Phase I/II

Modified dose escalation open label trial to evaluate efficacy of IP in Metastatic Breast Cancer.

​

​

​

​

​

​

​